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ABSTRACT 
Evaluation of Revised Criteria for the DSM-III 
Substance Use Disorders Diagnoses 
Guy Fish 
19 S 5 
This study was devised to evaluate a set of new criteria for 
the diagnosis of substance use disorders advanced for 
testing by an Ad Hoc committee of the American Psychiatric 
Association’s Work Group to Revise the DSM-III. Forty-one 
subjects on two general inpatient psychiatric wards were 
interviewed using The Diagnostic Interview Schedu1e<DIS> 
for making DSM-III substance use diagnoses and The 
Structured Clinician Interview for the DSM-11 I(SCID> for 
making substance use diagnoses with the revised criteria 
(DSM- I I I -R). Rates of diagnoses using these two systems 
were compared and bases for discrepancies sought. Rates of 
interview derived diagnoses were also compared with chart- 
diagnoses. Finally, correlations between types of major 
psychiatric disorder diagnoses and types of substance use 
disorder diagnoses were sought. DSM-III-R substance use 
diagnoses were found to have a high correspondence with 
DSM-III and were easier to use and more theoretically 
coherent. Chart diagnoses were shown to be largely 
for identification of those with substance use 
Although no strong trend was found for an 
of particular psychiatric disorders with types 





further investigation of this relationship. 
• 
This work is dedicated to my parents 
John and Juanita Fish 
"And though I have the gift of prophecy 
and understand all mysteries, and all 
knowledge; and though I have all faith, 
so as to move mountains, and have not 
love, I am no rhing.” 
l Corinthians 13:: 

V 
TABLE OF CONTENTS 
Acknowledgements . ii 
Abstract ... i i i 
Dedication  iv 
Introduction  
The DSM III 
Disease Classification . 
DSM-III: Goals, Merits, and Criticisms . 
Brief History of Substance Use Disorders Diagnosis 
The Who Model  
Specific DSM-III Substance Abuse Criticisms . 
Pro’s and Con's of the Proposed System . 
Aims of This Study . 
Methodology  
ResuIts  
D i scuss ion ..... 















The purpose of this project is to field test and 
evaluate new proposed criteria for Substance Use Diagnosis 
(SUDs) to be included in the revised Diagnostic and Statisti¬ 
cal Manual, third edition <DSM-I I I-R>. 
Since the Diagnostic and Statistical Manual, third 
edition 1DSM-III) was published in 1980, it has had a major 
impact on diagnostic practices in psychiatry.<l> However, 
for all of the diagnostic areas covered in the manual, 
shortcomings have become apparent; thus, a work group to 
revise the DSM-III has been organized and a revised version, 
the DSM- I I I -R, is being prepared for publication in 1987. 
One section of the DSM-III which has undergone considerable 
change is the Substance Use Disorders Section. Because of 
the scope of these changes, field testing is critical before 
they are adopted. To place this study in context we will 
first review the background of the DSM-III and DSM-III-R in 
general and the approach taken to diagnosing SUDS in 
specitic. 
THE DSM-I I I 
In 1974, the American Psychiatric Association's 
Committee on Research and Development commissioned a 
taskforce on Nomenclature and Statistics to develop the 
DSM-III. This project sought to create a guide for making 
psychiatric diagnoses compatible with the World Health 
Organizations's International Classification of Diseases, 
9th Revision (ICD-9). It was to be used by clinicians, 
researchers, and administrators of various theoretical 
. 
persuasions for diagnosis and to facilitate professional 
communication about psychiatric disorders.(l, IS) 
Ironically, after five years of open, controversial 
development including historically unique field trials <1, 
2l>, the critiques leveled against the finished product 
included terms such as reliability vs. validity, clinical 
usefulness, an atheoretical system, and abandonment of "time 
honored distintions” <S>: the same set of characteristics 
the authors of the DSM-III claim are its landmark strengths 
(S, l, IS, 21). This paradox points to the dilemma of 
attempting the classification of terms and disorders which 
are not fully defined. Given our similar task in this paper 
it is, again, pertinent to understand historically how we 
arrived at this point. 
DISEASE CLASSIFICATION 
Actually under study here are the recent histories of 
two concepts: disease, and c1 assification. A classification 
of diseases must adjust when the concept of what a disease 
is. and therefore how they are related to one another, 
alters.(24) This is seen quite commonly in internal 
medicine. Understanding details of a disease process like 
pancreatitis leads to the assembly of several key features 
like mid-epigastric pain and elevated enzyme levels as 
criteria by which to classify cases with similar clinical 




of this understanding of the process, the set of criteria 
may change, for example ignoring enzyme levels, and thus 
this disorder may, on the basis of similar other findings, 
end up classified with disorders of some other system. The 
same can be said in a general way regarding the 
understanding of psychiatric disorders and the resultant 
classificatory system. 
Early in the lSOO's, the limited understanding of 
psychiatric disease processes was evident in that the only- 
major psychological nosologic distinction was between 
insanity and idiocy as documented by Dr. Edward Jarvis’ 1S55 
survey of Massachusettes.(24> Late in the lSOO's the 
medical model of discrete multiple disorders crystallized 
(often termed the classic European or Kraeplinian concept). 
According to Klerman: 
"The highest principle for diagnosing 
and classifying disorders is the 
evidence for causation. This principle 
was accepted after a hard battle in the 
nineteenth century, primarily because of 
the impact of discoveries in biology: 
first, the discovery of bacteria and 
other microorganisms by the generation 
of Pasteur and Koch and, second, the 
examination of body tissues at 
autopsy... These techniques were applied 
to psychiatric syndromes with great 
success by our forerunners in the 
nineteenth century. So successful 1 were 
these efforts that most of the disorders 
that were unraveled are no longer with 
us. With the discovery of the 
spirochete and the advent of penicillin, 
general paresis, which accounted for 
about 10% of admissions to mental 
hospitals, is no longer a clinical 
problem. Pellagra, dementia, and 
delerium associated with nutritional 
. 
deficiency accounted for more than 4-0% 
of admissions to mental hospitals in the 
South."(8) 
Meanwhile Neurology had taken claim to all disorders of the 
CNS involving sensation and motor disturbances. 
Yet, just after world War I numerous psychiatric 
disorders remained which could not be explained by 
biological principles through the Kraepelinian concept of 
causation. Though European and Scandinavian studies 
continued in this tradition, by the post-wwil era American 
and Canadian psychiatry by and large explicitly rejected the 
classical medical model of discrete multiple disorders. 
Instead, America began to substantiate its unitary 
disease concept with Adolf Meyer's theory of social 
causation. The concept postulates that degrees of mental 
health and/or sickness are dependent upon the interaction of 
various factors (economics, social class, stress) upon the 
individual, as elucidated in a statement by the National 
Advisory Mental Health Council in 1955.<24) Alternatively, 
psychoanalysis, then at its most influential point, also 
de-emphasized descriptive classification of discrete 
disorders in favor of psychodvnamics formulations. 
However, around the same time, the advent of 
psychopharmoco1ogical therapeutics such as chlorpromazine 
led to a neo-Kraepelinian era.<8, 24) Therapeutic response 
to these psychotropic drugs supported anew the concept of 
discrete and heterogeneous psvchiatric disorders. 
Psychiatry continued on as a descriptive discipline as 
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evidenced by the emergence of the first DSM in 1952. However 
the evidence of clinical trials with chiorpromazine et.al. 
mandated closer scrutiny of the psycho-social and biological 
characteristics which indicate the presence of a particular 
clinical disease in a person since now particular diseases 
could be linked to specific treatment regimens.(24) 
Early on reseachers discovered much of the confusion 
over their findings was based on non-uniformity among 
clinicians and researchers in diagnosing patients. Ward, 
Beck, et.al. examined reasons for diagnostic disagreement in 
1961 and found the major factors to be: 32.5% due to 
diagnostician inconsistency (weighing symptoms differently, 
various interviewing techniques); and 62.5% due to an 
inadequate classification system (overly restrictive 
categories and unclear criteria>.(23> In a classic set of 
papers, Kramer and Zubin showed in 1969 that the cross 
national difference in the rates of schizophrenia and 
depression between the U.S. and the U.K. was largely 
artifactual due to differences in and useage of diagnostic 
Though the DSM-II, published in 196.3, organized itself 
to conform with the diagnostic categories outlined in the 
ICD-S for increased cross-national reliability, it continued 
to use a descriptive glossary as a classification system. 
As Spitzer, Endicott, and Robins indicate: 
"The clinician is forced to rely heavily upon 
his own concepts of the diagnostic categories 
because there are no formal definitions 
. 
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offered for most of them: features that are 
invariably present in the disorder are often 
not clearly distinguished from features that 
are commonly but not invariably present. In 
addition, there is no clear indication of 
which features distinguish a paticular 
condition from similar conditions. There are 
usually few, if any, guidelines as to which 
diagnoses are mutually exclusive or should be 
joint diagnoses to help the clinician faced 
with a patient with clinical features 
suggesting two different conditions. 
Sometimes the classification forces the 
clinician to choose between competing 
classificatory principles without a clue as 
to which takes precedence. Frequently, a 
classificatory principle is a function of 
tradition or of some hypothesized causal 
factor with little research evidence to 
support its validity. Finally, even when 
concepts are clearly presented, there are no 
operational rules that the clinician can 
apply to a given case to determine whether or 
not the criteria of a particular diagnostic 
category have been met."<20> 
Meanwhile. Feigner, Robins, and Guze at University of 
Washington, St. Louis, developed a set of operational 
criteria for psychiatric diagnosis which was published in 
l9/2.(6) The criteria were a distillate of many years of 
clinical research experience and were developed according to 
the "five phases” for establishing psychiatric diagnostic 
validity by Robins & Guze: l.) clinical description, 2.) 
laboratory studies, 3. > delimitation from other disorders, 
4. ) follow-up studies, 5. ) family studies. An expanded 
version of the "Feigner criteria” was created by the 
Clinical Research Branch of the NIMH and titled the Research 
Diagnostic Criteria < rdc >. 
Trials of these criteria led to higher than previously 
obtained re 1iabi1itv.<20) In a review of advances in 
■ 
psychiatric diagnosis Spitzer, Endicott et.al. in 1975<20) 
categorized sources of unreliability as falling into five 
categories similar to those of Ward, et.al.<23) They recog¬ 
nized the improvement standard interview schedules brought 
by decreasing observer variance. However the largest source 
of unreliability remained criterion variance. Thus they 
recommended that the future DSM-III adopt operational 
criteria, similar to Feigner and RDC, based on research 
evidence. The problem with adopting RDC criteria outright 
was that its development for research led to stringent 
criteria to assure a homogeneous sample which is too 
exclusive for general clinical use. 
In summary, for a long while psychiatric diagnosis was 
soley descriptive and inadequately operationalized. When 
support of descriptions of discrete disorders waned at the 
end of the Kraepelinian era theories of social causation and 
psychoanalysis took prominence. Then the weight of evidence 
for the theory of multiple discrete psychiatric disorders was 
inalterably shifted by the discovery of psychotropic medica¬ 
tions. Research to identify groups which could benefit from 
specific drugs evidenced the need to develop a more reliable 
system of psychiatric diagnosis and classification. It was 
recognized that these goals are preferable in clinical 
psychiatry also and as such the DSM-III, incorporating many 
of the advances such as the inclusion exclusion criteria 
seen in research, was developed as described below. 

DSM-III: GOALS, MERITS, AND CRITICISMS 
The DSM-III was developed to reflect psychiatry’s 
renewed commitment to systematic study of different 
disorders, and to provide accurate diagnosing with which to 
plan treatment programs. It also was needed to provide a 
common language for clinicians and researchers to 
communicate about disorders, assured that they spoke of 
comparable patient groups.(l) To that end the commissioned 
Task Force developed the following specific goals. 
"-clinical usefulness for making treatment and 
management decisions in varied clinical settings; 
-reliability of the diagnostic categories; 
-acceptability to clinicians and researchers of varying 
theoretical orientations; 
-usefulness for educating health professionals; 
-maintaining compatabi1itv with I CD-9, except when 
departures are unavoidable; 
-avoiding the introducton of new terminology and 
concepts that break with tradition, except when clearly 
needed; 
-reaching concensus on the meaning of necessary 
diagnostic terms that have been used inconsistently, 
and avoiding the use of terms that have outlived their 
use fu1 ness; 
-consistency with data from research studies bearing on 
the validity of diagnostic categories; 
-suitability for describing subjects in research studies 
-being responsive during the development of DSM-III to 
critiques by clinicians and researchers." (1) 
Other aspects commented on in the introduction of the manual 
include: its extensive field testing to demonstrate clinical 
acceptability and usefulness; its atheoretical approach in 
attempting to describe mental disorders by their clinical 
manifestations rather than etiology when such is unknown; 
and similarly its descriptive approach in classifying 
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disorders on the basis of shared clinical features. 
The DSM-III does attempt a definition of the term, 
mental disorders. However the introduction is quite clear 
in stating that "there is no assumption that each mental 
disorder is a discrete entitiy with sharp boundaries 
(discontinuity) between it and other mental disorders, as 
well as between it and No Mental Disorder."< T) It also 
denies the view that all individuals with the same disorder 
are alike in all important ways, but rather show at least 
the defining features of the disorder. The manual then 
attempts a systematic description of the disorder marshaling 
current knowledge regarding: essential features, associated 
features, age at onset, course, impairment, complications, 
predisposing factors, prevalence, sex ratio, familial 
pattern, and differential diagnosis.(l) Also important is 
the use of a multiaxial system to ensure representation of 
the patient as a whole and interactive individual with 
significant personality, biological, and social functioning 
dimensions. 
Again, one of the main goals of this undertaking was to 
increase diagnostic reliability. It is most significant to 
note that the authors of the DSM-III recognized that the 
criteria presented have not been fully validated.(l, IS) 
Rather, these specified criteria "provide explicit 
definitions for the categories, which would enable 
investigators to better study the comparative validity of 
alternative criteria."(20) 
Two years following the acceptance of the final draft 
i4 
1 
of the DSM-III by the APA a debate over its merits and 
faults took place at the annual APA convention. General 
criticisms of the manual are most succinctly stated in the 
transcript of that debate and are as follows: 
1. ) The manual is not valid cross-cu1tura11v. 
2. ) DSM-III ignores the nature of many disorders to 
exist as continua rather than as discrete entities. 
3. ) It ignores the role of clinical course* state vs. 
trait) in distinguishing between disorders . 
4. ) The axes are without a true biopsychosocial 
dimension and as such ignore pathogenesis in defining a 
symptom complex (adynamic). 
5. ) DSM-III compromises validity for reliability and 
thereby misrepresents the theoretical diversity present 
in American psychiatry by being atheoretical.<8) 
Those critiques were refuted individually by the 
defense team of the debate. However it suffices here to 
recognize the strongest arguement for the DSM-Ill's defense 
originates in a remark by the opposition. "The strategy of 
science is to construct hypotheses that seem to be good 
candidates for validity - decisions based on theory about 
the subject matter - and then to make these hypotheses as 
reliable as possible without relinquishing their relevance"(8) 
Then note the defense’s statement: "we did not insist that 
there be evidence that a diagnostic category was reliable 
before is could be included in the classification. In fact, 
our basic concern was clinical relevence."(8) 
we are thus left with a document which strove for both 
validity and reliability in diagnosis, but whose strongest 




data from tests of its hypothesized operational criteria. 
Let us turn our attention to the Substance Use Disorders 
Section's operational criteria. 
BRIEF HISTORY OF SUBSTANCE USE DISORDER DIAGNOSIS 
In this section we will outline the background 
developments leading to the revision of the Substance Use 
Disorders section of the DSM-III. 
Accurately defining substance use disorder has obvious 
legal importance. As well, it shares the importance of 
correct diagnosis for any disorder, namely: identifying 
subject groups for research comparison, identifying those 
with the disorder or at risk for developing it, channeling 
these groups to proper treatment modalities, and directing 
public allocation of funding to support these projects. 
The DSM-III section on Substance Use Disorders(SUDs) 
replaces the DSM-II Drug Dependence section and incorporates 
also the DSM-II Alcoholism category. This is significant 
for not only underscoring that the effects of the 
maladaptive use of alcohol are similar to those of other 
substances, but to recognize that the concept of SUDs owes 
much to the history of the development of the concept of 
alcoholism.*].) In our society the use of illegal substances 
has led many to presume that partakers are automatically 
abusers and addicts, thereby precluding the need for 
investigation as a disorder. However, given the wide social 
acceptance and use of alcohol, defining what is use vs. 
misuse has been the object of much research and 
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debate. This work can be considered as representative of 
the larger category of SUDs. Hence, we will focus this 
review on definitions of alcoholism. 
Babor details the history of the concept of drunkeness 
from colonial times onward.(2) Once viewed as a moral vice 
via free will, or, in the post-Revolutionary Era, as a 
disease caused by an agent (alcohol) or a process (like 
addiction), its first major step occured in the early 19th 
century when it was viewed in a semi-medical way as a 
moral-physical condition called intemperance. After being 
medicalized, the disease eventually made its way to become 
the physical and psychological entity we describe today. 
In terms of scientific definition of this entity, E.M. 
Jellinek is credited with having made the first major strides 
in this century.(2) After a review of the literature, 
Jellinek supported the distinction between alcoholism and 
alcohol addiction. Further, he defined relationships 
between these two entities and characterized their 
sub-classes based on descriptions in the literature. This 
work culminated in the publishing of his theories in the 
Disease Concept of A1coho 1ism.( 1960) Babor posits that 
since Jellinek's influential book, the efforts to redefine 
alcoholism have continued at the hands of various special- 
interest groups. 
These groups have by and large defined alcoholism and 
related terms (such as addiction, dependence, drug, 
tolerance, withdrawal, and consequences, among others) in 
ways that support their particular interest. For example. 
. 
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the American Medical Association has proposed classification 
of alcoholism under both the psychiatric and medical sections 
of the I CD. This not only downplays the stigma of alcoholism 
as a psychologic disease, but broadens the class of those 
qualified to treat alcoholics to include non-psychiatrists. 
Parenthetically, this also broadens the class of those 
eligible to receive insurance repayment for treating the 
alcoholic. Others, for similar reasons, have defined 
alcoholism in terms of behavioral, pharmacologic, and 
medical models. Unfortunately, many of "those involved in 
the generation of definitions have been remiss in explaining 
the scientific assumptions, semantic rules and practical 
objectives entering into their choice of words" leading to 
confusion within and between groups.(2) 
While these varying lines of thought were being pursued, 
changes in psychology, described earlier, began to have 
their effect on substance use diagnosis in two specific 
ways. First, the work of Feigner<6), the RDC, and others 
lead to the promulgation of formal inclusion and exclusion 
criteria for substance use diagnosis. This aided communica¬ 
tion by assuring that different groups were talking about 
similar subject populations, but did not aid in clarifying 
terminology since there was still no unifying conceptual 
perspective. The most notable product of the addition of 
inclusion criteria to defining alcoholism was the 
development of the DSM-III section on Substance Abuse. 
However this could be succinctly critiqued as a set of 
criteria in search of theoretical underpinnings. 
. 
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Secondly, the World Health Organization concurrently- 
developed its concept of the Alcohol Dependence Syndrome: a 
theoretical model of substance abuse including biologic, 
social, and psychologic dimensions around which terms such a 
"dependence” and "impairment" could take their meaning.(25) 
Likewise this might be termed a model without direct applica¬ 
tion to clinical and research work. It would seem logical 
to attempt to combine the atheoretical DSM-III criteria with 
the unapplied WHO model. Those involved in the creation of 
the DSM-III-R have attempted this to a large extent. But 
first let us take a brief look at the WHO model and examine 
the specific problems with the DSM-III Substance Abuse 
section. 
THE WHO MODEL 
The WHO was just one of many of the above mentioned 
groups working on defining terms in the area of substance 
abuse. As early as 1951 WHO attempted to define "alcoholism” 
and, for drugs under international control, addiction.(25) 
Many stages of revision occurred, including: defining drug 
addiction versus habituation, replacing both of those with 
the concept of dependence, and distinguishing between 
psychic and physical dependence. In 1977 a synthesis was 
announced by a WHO subcommittee which proposed a dependence 
syndrome.(25) 
"The alcohol dependence svndrome is manifested by 
alterations at the behavioral, subjective, and 
psvchobio1ogica1 levels with, as a leading symptom, 
an impaired control over the drug ethyl alcohol. 
The alcohol dependence syndrome exists in degrees. 
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Its varied manifestations are influenced by 
modifying personal and environmental factors so as 
to give many different presentations ... Not all 
people manifesting alcohol related disabilities 
are alcohol dependent,...” (25) 
This alcohol dependence syndrome was expanded upon in a 
later WHO monograph on nomenclature and c1assification.(25) 
The model was used to explain initiation, continuation, and 
discontinuation of drug and alcohol use. Also several terms 
were either modified, added, or dropped. For example, drug 
abuse was changed to the more defined collective terms: 
unsanctioned use, hazardous use, dysfunctional use, and 
harmful use; neuroadaptation was added to describe patients 
maintained on drugs causing tolerance and withdrawal but who 
have not the desire to continue taking drugs. But the most 
noteworthy distinction of the dependence syndrome model was 
the concept of there being a constellation of disabilites 
which occured across different categories of drugs and that 
these disabilities could exist in varying degree: a major 
departure from the Kraepelinian "all or-none" concept of 
discrete diseases. 
SPECIFIC DSM-III SUBSTANCE ABUSE CRITICISMS 
An overview of the DSM-III Substance Use Disorder 
section is provided by Spitzer, Williams, and Skodo1(21): 
"This section of the DSM-III includes disorders in 
which there are behavioral changes associated with more 
or less regular use of substances that affect the 
central nervous system and that in almost all 
subcultures would be viewed as undesirable. This 
category combines the DSM-II categories of Drug 
dependence and Alcoholism to emphasize that the effects 
of the maladaptive use of all substances of potential 






The Substance Use Disorders are divided into two major 
types: Abuse and Dependence. In general. Substance 
Abuse is defined by a pattern of pathological use for 
at least one month that causes impairment in social or 
occupational functioning. Examples of pathological use 
include inability to reduce or discontinue use or 
remaining intoxicated throughout the day. Substance 
Dependence is defined by the presence of tolerance or 
withdrawal. For Alcohol and Cannabis Dependence, 
impairment in social or occupational functioning is 
also required.... 
Many substances are associated with both abuse and 
dependence, including alcohol, barbituates or similarly 
acting sedatives or hypnotics, opioids, amphetamines or 
similarly acting sympathomimetics, and cannabis.... 
Substances for which abuse but not dependence has been 
demonstrated include cocaine, phencyclidine (PCP) or 
similary acting ary1 eye 1ohexy1 amines, and 
hallucinogens. (Phencyclidine is distinguished from 
hallucinogens despite some similarities in their 
effects.)... Polysubstance Use may be classified as 
such when it is not possible to identify each of the 
subtances involved. 
For each substance Use Disorder in the DSM-III, the 
pattern of use or course of the disorder is coded in 
the fifth digit as continuous, episodic, or in 
remission. 
Rounsavilie, Spitzer, and Williams, in conjunction with 
an advisory committee on the Substance Abuse section to the 
Work Group to Revise the DSM-III, have advanced a number of 
proposals for modification of the above in response to 
solicited critiques.(16) The critiques were(14): 
1. ) The term "Substance” in the class title Substance Use 
Disorders is believed to be too broad and easily misinter¬ 
preted to include non-psvchoactive substances such as food 
or water. 
2. ) Difficulties with the current distinction between abuse 
and dependence including: problems using social and 
occupational consequences to define "abuse"; weakness of 
tolerance or withdrawal as a required criterion for 
dependence; and inconsistencies in the relationship of abuse 
to dependence for different substances. 
3.) The requirement of a duration of substance use for one 
. 
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month to meet criteria for "abuse" does not specify which 
diagnostic criteria need to be present for that month, and 
it is insensitive to the discontinuous though pathologic 
pattern of use associated with some drugs, e.g. PCP. 
i.) Current fifth digit coding (to describe the course of 
the disorder as l = continuous, 2 = episodic, 3 = in remis¬ 
sion, and 0 = unspecified) is limited in utility as 
categories are frequently not mutually exclusive and remis¬ 
sion is often incomplete in these disorders. 
5.) The poly-substance use diagnoses are inadequate in 
being overly specific and in not conveying the commonly 
seen pattern of an individual indiscriminately using various 
drugs singly or in combination for frequent intoxication. 
The advisory group's proposals hinge on the modification of 
the terms "abuse” and "dependence” . As this change impacts 
most on this paper, it is listed last in the below proposals 
and is presented in most detail. The proposals are: 
a. ) Replace the term "substance " with "psvchoactive 
substance"; thus "Psvchoactive Substance Use Disorders”. 
b. ) Eliminate the duration criterion since the new criteria 
for dependence imply a clinically significant duration of 
the disorder. 
c. ) For individuals not in remission the clinician is asked 
to specify the severity of the dependence as mild, moderate, 
or severe. 
d. ) Replace the three categories of mixed substance abuse 
or dependence with a new category - Poly-Psychoactive 
Substance Dependence for when there is indiscriminant use of 
more than one drug without any one drug predominating. 
E*) l. Remove the "abuse" cat egory and broaden the 
definition of dependence to a syndrome of clinically 
significant behaviors that indicate a serious degree of 
involvement with a psvchoactive substance. The proposed list 
of criteria (Table l) will apply to each class of 
psvchoactive substances. Individuals meeting three of more 
of these criteria would receive a diagnosis of dependence. 
Note that social and occupational consequences are not 
included in the proposed criteria. When these behaviors are 
implicated it is the drug-using behaviors and not the 
consequences that are considered in determining whether or 
not a given criterion is met. 
2. Create a new category of "Psvchoactive Substances 
Neuroadaptation Syndrome" for individuals whose 
, 
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physiological adaptations to high doses of psychoactive 
substances did not arise from their own behavior and for 
whom the dependence syndrome as defined in Table l is not 
present (e.g., heroin dependent newborns). 
3. For individuals who have experienced adverse social 
consequences of substance use but who do not have sufficient 
symptoms to qualify for a diagnosis of the expanded depend¬ 
ence category, the clinician can diagnose individual episodes 
of intoxication using the criteria listed under Substance- 
Induced Organic Mental Disorders. Most such individuals 
would not have qualified for a DSM-III diagnosis of 
substance abuse because of the requirement for a "pattern of 
pathological use." 
PRO’S AND CON'S OF THE PROPOSED SYSTEM 
As Rounsavilie, et.al.(l6) point out, the proposed 
system meets the major critiques described by: removing 
social consequences from the criteria for diagnosing 
substance use disorders; retaining tolerance and withdrawal 
symptoms as indices of dependence but placing far less 
emphasis on these physical symptoms in detecting and 
describing a pervasive and complex syndrome of pathological 
behavior; and making the criteria consistent across 
different substance use categories. 
For substances other than alcohol, the broadened 
concept of dependence is consistent with earlier definitions 
utilized in DSM-II. It also reflects the theoretical and 
empirical advances found in the above described "dependence 
syndrome" which underlies compulsive use of all classes of 
psvchoactive substances. It is hoped that nearly all of 
those individuals who met DSM-III criteria for substance 
"abuse" would also meet the proposed criteria for "dependence" 
because "abuse" required a "pattern of pathological use" 
which is represented by several of the proposed criteria in 
Table l. Failure to do so would be a serious drawback. 
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Also the broadened term "dependence" may confuse those 
accustomed to the DSM-III definitions or appear inferior due 
to the loss of the ability to denote severity without the 
term "abuse". It should be noted that the distinction 
between "abuse" and "dependence" was new with DSM-III. The 
new criteria allow for denoting severity by use of the fifth 
digit. 
Finally, the new criteria, relative to DSM-III, may 
fail to provide a diagnosis for certain individuals with a 
significant, in terms of adverse social consequences, but 
episodic pattern of substance abuse. Yet, such individuals 
could receive a diagnosis for the individual episodes of 
intoxication. Moreover, such individuals would not have met 
DSM-III criteria for abuse because of the need to 
demonstrate a "pattern of pathological use" (with the one 
month requirement). 
AIMS OF THIS STUDY 
The purpose of this study is to evaluate the proposed 
DSM-III-R substance use dependence criteria in a field trial 
with psychiatric inpatients. The major aim is to assess the 
level of agreement between the proposed DSM-III-R criteria 
and the existing DSM-III criteria. The changes present in 
the DSM-III-R are not without potential effects on the rates 
of diagnosis of the psvchoactive substance use disorders. 
In general one could predict the revised criteria to have: 
a.) No agreement with DSM-III 
b.) Poor agreement with DSM-III 
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c. ) Good agreememt with DSM-III and DSM-III R proving 
d. ) Good agreement with DSM-III and DSM-III R proving 
Specifically, these are arrived at by combining a number of 
factors which could alter rates: 
1. ) As "abuse" was defined by social consequences, 
removal of said criteria could result in those who 
would have been diagnosed as abusers being missed. 
Thus DSM-III R rates could be lower. 
2. ) The merging of the "pathological pattern of use” 
portion of the DSM-III abuse criteria with the 
criteria for dependence in DSM-III R reduces 
reliance on tolerance and withdrawal for 
dependence and leads to greater theoretical 
coherence. But it may also greatly increase the 
rates of those being diagnosed as dependent. 
3. ) Removal of the one month duration criteria may 
yield an increase in rates without this 
restrictivee element. 
4. ) Creating a common set of criteria for all drug 
classes may, again, favor concepts of a 
dependence syndrome for all drugs, but in criteria 
not being "tailored" rates of diagnosis of 
dependence may change unpredictably from one drug 
class to the next. 
It is the purpose of this paper to discover through 
field testing of these two sets of criteria the consequences 
the above changes will have on rates of diagnoses. Specific 
aims are: 
A. To assess the extent to which proposed new 
(DSM-IIIR) criteria agree with old (DSM III) 
criteria regarding the presence or absence of 
substance use disorders, and to investigate the 
types of disagreement. 
B. To assess the agreement between DSM-III and 
DSM-1 I I -R diagnoses versus chart diagnoses as an 
evaluation of source of data as a factor in 
determining rates. (7, n, 12) 
C. To assess the relationship between primary psychi- 
■ 
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atric diagnoses and classes of substance abuse. 
METHODOLOGY 
1. Subjects and setting 
Subjects for this study were 41 inpatients on a mixed 
general psychiatry short term unit. On this ward 
approximately 20-30% of patients are treated for problems 
related to abuse of psvchoactive substances. For field 
testing purposes, this sample was useful because it enables 
a comparison of methods for discriminating those with a 
diagnosis of substance use disorders from those with other 
psychiatric diagnoses. 
Patients for this study were interviewed 7-14 days 
after admission to the ward and were approached for 
interview only after psychotic symptoms or severe affective 
pathology had abated. Before approaching a patient for 
participation in the study, the interviewer first 
ascertained from the primary clinician that the patient was 
not currently psychotic or otherwise unable to give informed 
consent to be interviewed. The patient was then approached 
by the interviewer, the nature of the study explained, and 
the written consent obtained before proceeding with the 
interview. 
2. Assessments 
A. Diagnosis of Substance Use Disorders 
The criteria used for making the substance use 
diagnosis were the currently utilized criteria from the 
■ 
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American Psychiatric Associations's DSM III and the proposed 
criteria for the revised form, the DSM III-R. Structured 
interview schedules have been developed for making the DSM 
III and DSM III-R diagnoses which allow for consistency and 
thoroughness of coverage. For the DSM III the Substance Use 
portion of the Diagnostic Interview Schedule (DIS) was used 
(13); for the DSM III-R the Substance Use section of the 
Structure Clinician's Interview for the DSM III-R (SCID) was 
used (22). 
B. Substance Use Related Problems 
Evaluation of substance use related problems were 
performed using the Addicton Severity Index (ASI; 10) a 
structured clinician's interview which assesses objective 
and subjective information about impairment in six areas: 
substance use problems, medical problems, social problems, 
psychological symptoms, occupational problems, and legal 
prob1ems. 
C. Handling of Completed Forms 
For protection of subjects from legal reprisal, no 
names or identifying codes were used on the forms. Forms 
displayed a case number (APT#) randomly assigned independent 
of subject identity or order in the study solely for the 
purpose of distinguishiing between sets of responses. No 
record of which subject used which forms were kept. 
Information collected in the interview was kept confidential 
from all those outside the research staff including the 
patient's clinicians. The completed forms were kept locked 




Ratings were performed by one of two graduate level 
evaluators who were trained for consistency in interview 
technique by Dr. Bruce Rounsaville. 
4. Data Analysis 
This was be designed to achieve the three aims of the 
study listed on page 20. 
To assess agreement between DSM III and DSM III-R 
computation of sensitivity and specificity were performed 
using DSM III as the criterion against which DSM III-R was 
evaluated. 
To assess the agreement betweem DSM-III and chart 
diagnoses cross-tabulations of sensitivity and specificity 
were performed, again, using DSM-III as the rule. 
To assess the relationship between primary psychiatric 
and substance use disorders a significant findings from a 
cross-tabulation will be submitted to Chi-square testing. 

RESULTS 
Question #1: Agreement between DSM-III and DSM-III-R 
Of the 41 subjects interviewed, approximately 70.4% of 
those diagnosed by DSM-III (N=19) and 6S.9% of those by 
DSM-III-R (N=20> were polysubstance users. 
Subject classification by DSM-III diagnoses (table 2) 
indicates Alcohol as the most commonly used agent as 
assessed by having the most abusers/dependent overall 
(N=22). Opiates were the second most commonly used (N=14) 
followed by Cocaine ( N = 9 ). Cannabis, Barbituates, 
Amphetamines, and "Other” were all less commonly used at 
about the same rate ( N = '6 ). Hallucinogens were the 
least commonly used < N = 1 ). Rates of dependence given 
DSM-III criteria resulted in an order from most to least 
dependence causing of: Alcohol(N=17 >, Opiates <N=14 ), 
Barbituates (N=6 ), and Amphetamines (12.2%). 
Table 2 about here 
According to the DSM-III-R format (table 3), the order 
of highest dependence is: Alcohol <N = 22 ), Opiates <N=14 ), 
Cocaine (N=ll ), Other (N=S >. Barbituates (N=7 ), 
Amphetamines < N = 6 ), and Hallucinogens <N = 2 ). 
Table 3 about here 
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Comparison of DSM-III with DSM-III-R diagnoses for 
presence or absence of abuse or dependence for each 
individual in each substance class was performed. Counts of 
subjects falling into the "diagnosis/no diagnosis” 
categories allowed are presented in table 4. 
Table 4 about here 
Sensitivity/specificity measurements, using DSM-III as the 
rule by which DSM-III-R was judged, were performed. In four 
out of eight substance categories, DSM-III-R showed perfect 
sensitivity 1100%) with high (>93%) specificity. In the 
remaining four categories, sensitivity ranged from 91% for 
Alcohol to 67% for Barbituates with Cannabis and 
Amphetamines holding the mid-ground at S6% and 83% 
respectively. Specificity of DSM-III-R for diagnosing these 
four categories remained high (>89%). 
Particularly notable are six cases in the tally where 
DSM-III diagnosed abuse or dependence and DSM-III-R did not. 
These six instances were divided among four subjects. In 
the first two cases, abuse of a substance (Alcohol) was 
diagnosed in DSM-III by means of social and occupational 
consequences and a pathological pattern of use; whereas 
DSM-III-R noted only social/occupational consequences in one 
case and tolerance with a pathological pattern in the other 
case. In the next two other cases (Cannabis and Barbitu¬ 
ates), the subjects did not meet the abuse criteria, yet 
dependence was diagnosed by DSM-III where tolerance and 
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either pathological pattern or soc/occ consequences were 
present. Similar to the above, tolerance and a pathological 
pattern were seen in one case using DSM-III-R, and the other 
case showed only soc/occ consequences. In the last pair of 
cases, DSM-III made the diagnoses of dependence (Ampheta¬ 
mines and Barbituates) by virtue of tolerance and fully 
meeting abuse criteria. Tolerance and a pathological 
pattern was seen by DSM-III-R in one case, and a pathologic¬ 
al pattern with consequences and no tolerance characterized 
the other case. Degree of impairment or consequences were 
consistent with answers from corresponding ASI questions. 
Question #2: Agreement between diagnoses of substance use 
disorders(SUDs> from interviews versus charts 
Only four specific chart diagnoses of SUDs were noted 
!table 5). The remainder of the subjects received either no 
drug disorder diagnosis when such was indicated by DSM-III 
(19.5%) or the diagnoses of "unspecified dependence”, "other 
mixed or unspecified abuse", or "dependence on combination 
of opioid and other non-alcoholic" (combined total = 26.8%). 
Table 5 about here 
Of the specific diagnoses of substance use. Alcohol abuse 
was highest at 7.3% (N=3) followed by Alcohol and Opioid 
dependence, both 4.9% (N=2>, and final 1v Cocaine ab use at 
2.4% (N=1). A 1 1 these rates are much lower than those by 
DSM-III as assessed by comparison in table 6. 
■ 
Table 6 about here 
Sensitivities range from none (hallucinogens) to 83.3% 
(amphetamines). Specificity ranges from 73% to 100%. 
Question #3: Correlation between primary psychiatric and 
substance use diagnoses 
The primary psychiatric diagnoses among the group of 41 
subjects were subsummed under the headings of the major 
psychiatric disorders: Affective , Schizophrenic, Other 
psychotic. Adjustment, and "Other” disorders (table 7). All 
of the 41 subjects carried primary psychiatric diagnoses on 
Axis I with the exception of one who had a personality 
disorder without substance use. One item of data was lost 
leaving 39 diagnosed among the above 5 disorders. 
Table i about here 
The largest group was those having Affective disorders 
(31.7%) followed by those with Adjustment disorders (29.3%). 
The grouping "Other”, comprised of six individuals with 
eating, dysthymic, organic, or anxiety disorders was third 
largest at 14.6%. Schizophrenics and Other Psychotic 
Disorders represented 9.7% each. 
Regarding each instance of substance abuse as an indi¬ 
vidual case, a cross tabulation was performed to determine if 
any systematic pattern of concordance developed between types 
' 
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of substance use and types of mental disorder (table 8). 
Table S about here 
In only a few instances did there appear to be an association 
between categories of psychiatric diagnoses and a substance 
use disorder. These were analyzed using the Yates correction 
for Chi-square testing after collapsing datum to fourfold 
tables. Examples using the most promising datum (those for 
alcohol and opiates vs. affective disorders) are provided in 
table 9. For each of these there was no significance as p 
. 10 
Table 9 about here 
DISCUSSION 
Question #1: Agreement between DSM-III and DSM-III-R 
The revised DSM-III criteria are found useful in this 
study due to several strengths. The first strength results 
from the nature of its design; namely, it is consistent 
across drugs. This was accomplished by incorporating 
advances in the understanding of the nature of substance 
abuse represented by the WHO dependence syndrome. This ap¬ 
proach has the advantage of focusing the investigator/cl ini - 
cian on the overall similarity in the pattern of substance 
dependence rather than highlighting patterns specific to 
each drug which may not bear upon decision making 
, 
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for diagnosis or therapy. This should facilitate research 
by bringing together knowledge on drug use in different 
substance classes previously separated by probably less 
important drug-specific details of use/dependence. Although 
this represents a major break from the atheoretical stance 
of DSM-III, the manual states it intended to be atheoretical 
only where wide disagreement in the field on the nature of a 
disorder dictated that they advance no particular theory. 
As the WHO model has gained acceptance in research and clin¬ 
ical settings, it is appropriate to incorporate this theo¬ 
retical understanding into DSM-III-R. As remarked upon ear¬ 
lier in this paper, such a change in the understanding of a 
disease process necessitates a change in c1 assifactory 
systems. 
This change has a direct result which is the second 
strength of these revisions: a more practical method of 
diagnosis across drugs. This results from systematizing and 
simplifying inquiry regarding patterns of use for different 
drugs. Further, even with the use of a diagnostic tool such 
as the DIS, analysis of subject responses to make a diagnosis 
required sophisticated programming with a complex set of 
branch and loop decisions. The utility of the DSM-III is 
seen in its straightforward method of simply counting the 
number of positive responses for each drug class and assigning 
a diagnosis of dependence to those with class counts of 
three or greater. This writer found it a much simpler 
system to comprehend and utilize. Such should be the 




Third, despite numerous structural changes, the DSM-III-R 
showed close agreement with the DSM-III. By gross comparison 
the rates of diagnoses for each substance class are either 
equal or DSM-III-R identifies no more than 5% more users 
than does DSM-III (tables 2 and 3). The analysis represented 
in table 4 shows that DSM-III-R confirmed a DSM-III diagnosis 
in 65 cases, found and diagnosed and additional 14 cases, 
and failed to confirm a DSM-III diagnosis in only 6 instances. 
With the exception of the Barbituates substance class, the 
sensitivity/specificity indices for each class are very 
high. There are notably small ends for Barbituates such 
that variance in diagnosis similar to that which occurred in 
the Alcohol analysis led to markedly different sensitivity 
results (66.7% and 90.1%, respectively). 
For half of the substance classes, DSM-III-R is less 
restrictive than DSM-III (false - = 0% with reasonable 
false + rates). But for Barbituates, Amphetamines, Alcohol 
and Cannabis DSM-III-R is apparently more restrictive 
(false - = 9.1 to 33.3% with reasonable false + rates). 
The cases accounting for the latter set of data were 
analyzed. The basic question to be answered was why the 
DSM-III-R, easier to diagnose dependence with since it 
merged abuse into dependence, should have failed to detect 
several cases found by DSM-III. For two of these cases, the 
fault seems to lie with DSM-III for placing to high a value 
on the presence of tolerance since these two cases did not 
make DSM-III criteria for abuse. In two other cases, DSM-III 
abuse and dependence criteria were met while DSM-III-R 
■ 
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simply registered only two positive responses. It maybe 
that here DSM-III is not sensitive enough either in defining 
the best criteria for dependence, or in requiring three 
(instead of maybe two) positive reponses. 
It must be noted that this study has evaluated the 
methods using a small number of subjects and that the trends 
noted here would require replication in a larger trial. 
The high level of agreement between DSM-III and 
DSM-III-R may be seen as an indication that the proposed 
changes are of little import in that they function almost 
identically in comparison with the original system. 
However, given the greater theoretical and practical 
cohei cr.^e of the revised system, the new criteria may have 
the benefits of placing emphasis on those aspects of 
substance abuse which are most salient. Also, it may 
encourage more systematic investigation of commonalities 
across types of substance abuse. 
Question #2: Agreement between interview and chart 
diagnoses as sources 
As the results indicate (table 6) there is poor 
agreement between DSM-III interview derived and chart 
derived diagnoses. 
Whereas nearly all of those who received a chart 
diagnosis of substance use disorder were also diagnosed by 
DSM-III, only 70.4% of those diagnosed by DSM-III were 
represented in the chart diagnoses. This indicates that, by 
by comparison with interview derived diagnoses, chart 

diagnoses are insensitive. The possible reasons for this 
are that either the clinicians are not specifically looking 
for possible existant substance use disorders or that 
subjects are evading diagnosis by denying symptomologv. 
Given the nature of the scheduled interviews used for 
this project (where direct questions concerning substance use 
were asked subjects), and given the consistency of responses 
between questions asked for DSM-III and DSM-III-R, one must 
posit that, if asked directly, many subjects are willing to 
admit to significant substance use pathology. This is the 
basis for further justifying the use of standard interview 
schedules - at least on psychiatric inpatient wards - to 
better identify those who need to be directed to appropriate 
therapy, or to identify substance use as a contributing 
factor to their psvchopatha 1ogy. 
Question #3: Correlation between primary psychiatric 
diagnosis and substance use diagnoses 
A careful look at table 8 revealed no strong trends and 
the sample size was too small to test for statistically sig¬ 
nificant association between any type of primary psychiatric 
diagnosis and substance use disorders. Chi-square testing 
reguires an expected frequency of 5 in a cell. Even so, for 
those groups where sufficient counts were possible after 
collapsing several categories, there was still no statisti¬ 
cally significant concordance. 
Yet, even with these shortcomings, the results suggest 
an interesting trend, namely, substance use disorders are 

spread fairly evenly across all categories of primary 
psychiatric disorders. This seems to indicate that 
substance use disorders should be suspected in all major 
classes of psychiatric inpatients. Thus, no major 
psychiatric diagnostic group is immune from the possibility 
of concommitant substance use disorder. Even schizophrenics 
appear sufficiently resourceful to procure and use illicit 
substances. 
CONCLUSIONS 
Based on findings from this study, the use of the 
revised DSM-III criteria for psychoactive substance use 
disorders is subtantiated on the basis of: 
- High degree of agreement with the current system, DSM-III 
- Theoretical coherence (WHO model) underlying criteria 
- Greater ease in making the diagnosis with DSM-III-R 
It is recommended that standard interview schedules be 
employed more for improved detection of substance use 
disorders on general psychiatric wards. Substance use seems 
to be prevelant among all major psychiatric inpatient 
groups. Moreover, chart diagnoses appear to reflect an 




PROPOSED DSM-IIIR CRITERIA FOR DIAGNOSES 
OF PSYCHOACTIVE SUBSTANCE DEPENDENCE 
1. Repeated effort to cut down or control substance abuse. 
2. Often intoxicated or impaired by substance use when 
expected to fulfill social or occupational obligations (e.g. 
doesn't go to work because hung over or high, goes to work 
high, drives when drunk). 
3. Tolerance: need for increased amounts of substance in 
order to achieve intoxication or desired effect, or 
dimimished effect with continued use of same amount. 
4. Withdrawal: substance specific syndrome following 
cessation or reduction of intake of substance. 
5. Frequent preoccupation with seeking or taking the 
substance. 
6. Has given up some important social, occupational or 
recreational activity in order to seek or take the substance 
7. Often uses a psychoactive substance to relieve or avoid 
withdrawal symptoms (e.g., takes a drink or diazepam to 
relieve morning shakes) (NOTE: should this include taking 
a drug to relieve intoxication from another drug? If so, it 
needs to be added.) 
8. Often takes the substance in larger doses or over a 
longer period than intended. 
9. Continuation of substance use despite a physical or 
mental disorder or a significant social problem that the 
individual knows is exacerbated by the use of the substance. 
10. A mental or physical disorder or condition that is 
usually a complication of prolonged substance use (e.g., 




CLASSIFICATION OF SUBJECTS AS NON-ABUSERS, ABUSERS, OR 
DEPENDENT ACCORDING TO DSN-I I I 
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CLASSIFICATION OF SUBJECTS AS DEPENDENT OR NOT DEPENDENT 
USING DSM-III-R 
Substance disorder N 
























































COMPARISON OF CLASSIFYING SUBJECTS AS PSYCHO-ACTIVE 
SUBSTANCE USERS USING DSM-III vs. DSM-III-R 
SUBSTANCE | DSM- III-R Sensi- Speci- Fa 1se + False- 
DSM-III diagnosis tivity ficity (b / b + d) (C/A+C) 
cliagnosisl Dependent None (A/A+C)* (d / d + b) 
ALCOHOL 
Dependence 17(a) 0(c) 
Abuse 3 < a ’ ) 2 (c ' ) 1 90.9% S9.5% 10.5% 9.1% 
No abuse 2(b) 17(d) 
CANNABIS 
Dependence 3 1 
Abuse 3 0 85.7% 9 1.2% 8.8% 14.3% 
No abuse 3 31 
AMPHETAMINES 
Dependence 4 l 
Abuse 1 0 83.3% 97 . 1% 2.9% 16.7% 
No abuse 1 34 
BARBITUATES 
Dependence 4 2 
Abuse 0 0 66.7% 91.4% 8.6% 33.3% 
No abuse 3 32 
OPIATES 
Dependence 14 0 
Abuse 0 0 100.0% 100.0% 0.0% 0.0% 
No abuse 0 27 
COCAINE 
Abuse 9 0 
No abuse o 30 100.0% 93 . S% 6.2% 0.0% 
HALLUCINOGENS 
Abuse i 0 
No abuse i 39 100.0% 97.0% 3.0% 0.0% 
OTHER 
Abuse 6 0 
No abuse o 33 100.0% 94.3% 5.7% 0.0% 




CLASSIFICATION OF SUBJECTS BY END-OF- 
DIAGNOSIS OF SUBSTANCE USE DISORDERS 
-TREATMENT CHART 
Diagnoses N = 4 1 % 
Alcohol abuse (30500) 3 7.3 
Alcohol dependence (30390) 2 4.9 
Opioid dependence (30400) 2 4.9 
Cocaine abuse (30560) 1 2.4 
Unspecified Substance Dependence 
(30490) 
1 2.4 
Other, mixed or unspecified substance 7 17. l 
abuse (30590) 
Dependence on combination of opioid 







COMPARISON OF CLASSIFYING SUBJECTS AS PSYCHO-ACTIVE 
SUBSTANCE USERS USING DSM-III vs. CHART DIAGNOSES 
SUBSTANCE | Chart Sensi- Speci- False+ False- 
DSM-III | Diagnosis tivity ficitv (b/b+d) (C/A+C) 






3 (a ’ ) 
0(b) 
5(c) 
2 ( C ' ) 
19(d) 
















82.9% 17.1% 16. i 
BARBITUATES 
Dependence 5 1 
Abuse 0 0 
No abuse 6 29 










'8.6% 92.6' 21.4% 
COCAINE 
Abuse 
No abuse z / I 7.8% S4.4% 15.6% 
HALLUCINOGENS 
Abuse 0 1 
No abuse ll 30 0.0% 73.2% 26.8% 100.0% 
OTHER 
Abuse 
No abuse 28 66.7% 80.0% 20.0' 33.3% 




CLASSIFICATION OF SUBJECTS BY PRIMARY CHART PSYCHIATRIC DX 
Disorder diagnosed N = 4 1 % 
Affective 13 31.7 
Schizophrenic 4 9.7 
Other Psychotic 4 9.7 
Adjustment 12 29.3 
Other * 6 14.6 
N o Dx * * 2 4.9 
41 100.0 
* Eating(2), Dysthymic(2), Organic and Anxiety disorders 
* * Axis II Personality disorder only(l), Lost data (l) 
TABLE S 
CROSS-TABULATION OF SUBSTANCE USE DIAGNOSES USING DSM-III or 
DSM-III-R (> vs. PRIMARY PSYCHIATRIC DISORDERS 
Agent of abuse | 
or dependence 




( C ) N 
(4) 




( f ) N 
(2) 
Alcohol (IIKIII -R >) 7(7) 2(1) 2(2) 5 ( 6 > 5(5) Kl) 





1(1) 0(1) 1(0) 2(2) 0(0) 
Barbituates 1(3) 1 ( 0 ) 0(1) 2(1) 2(2) 0(0) 
Opiates 6(6) 1(1) 1(1) 3(3) 3(3) 0(0) 
Cocaine 3(3 ) 0(0) 0(2) 4<4) 2(2) 0(0) 
Hal 1ucinogens Kl) 0(0) 0(1) 0(0) 0(0) 0 < 0 ) 
Other 2(4) 0(0) 0(0) 3(3) 1 ( 1 ) 0 < 0 ) 
* a= Affective, b= Schizophrenic, c= Other Psychotic, d= Ad¬ 



























6(6.02) | 13(12.98)! 19 
Total 
1 
13 28 41 
























13 28 41 
Chi-square . 563 ; p > . 10 
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